Ciprofloxacin vs Lenvatinib Mesylate

## Ciprofloxacin vs Lenvatinib Mesylate: Overview

This comparison examines the pharmacological differences between **Ciprofloxacin** and **Lenvatinib Mesylate**.

## Mechanism of Action

**Ciprofloxacin**: Inhibits bacterial DNA gyrase and topoisomerase IV.

## Pharmacokinetics

**Half-life**: Ciprofloxacin — 4 hours; Lenvatinib Mesylate — N/A.

## Chemical Properties

**Molecular Formula**: Ciprofloxacin — C17H18FN3O3; Lenvatinib Mesylate — N/A.

**Molecular Weight**: Ciprofloxacin — 331.3460 g/mol; Lenvatinib Mesylate — N/A.

**Type**: Ciprofloxacin — Small molecule; Lenvatinib Mesylate — Small molecule.